224 related articles for article (PubMed ID: 30266676)
21. Shortening of telomeres in recipients of both autologous and allogeneic hematopoietic stem cell transplantation.
Akiyama M; Asai O; Kuraishi Y; Urashima M; Hoshi Y; Sakamaki H; Yabe H; Furukawa T; Yamada O; Mizoguchi H; Yamada H
Bone Marrow Transplant; 2000 Feb; 25(4):441-7. PubMed ID: 10723589
[TBL] [Abstract][Full Text] [Related]
22. Outcome of Second Allogeneic Hematopoietic Cell Transplantation after Relapse of Myeloid Malignancies following Allogeneic Hematopoietic Cell Transplantation: A Retrospective Cohort on Behalf of the Grupo Español de Trasplante Hematopoyetico.
Orti G; Sanz J; Bermudez A; Caballero D; Martinez C; Sierra J; Cabrera Marin JR; Espigado I; Solano C; Ferrà C; García-Noblejas A; Jimenez S; Sampol A; Yañez L; García-Gutiérrez V; Pascual MJ; Jurado M; Moraleda JM; Valcarcel D; Sanz MA; Carreras E; Duarte RF
Biol Blood Marrow Transplant; 2016 Mar; 22(3):584-8. PubMed ID: 26631751
[TBL] [Abstract][Full Text] [Related]
23. Improved Long-Term Net Survival after Allogeneic Hematopoietic Cell Transplantation in Patients with Hematologic Malignancies over Two Decades.
Ohbiki M; Ito Y; Inamoto Y; Miyamura K; Uchida N; Fukuda T; Fujiwara H; Nishida T; Hayashi M; Tanaka M; Kawakita T; Ikegame K; Katayama Y; Ara T; Ichinohe T; Kiyoi H; Matsuo K; Atsuta Y
Transplant Cell Ther; 2023 Dec; 29(12):768.e1-768.e10. PubMed ID: 37739224
[TBL] [Abstract][Full Text] [Related]
24. Pulmonary Impairment after Respiratory Viral Infections Is Associated with High Mortality in Allogeneic Hematopoietic Cell Transplant Recipients.
Sheshadri A; Chemaly RF; Alousi AM; Shah PK; Rondon G; Bashoura L; Kmeid J; Azzi J; Blanco DW; Kaous M; Dickey BF; Champlin RE; Shah DP
Biol Blood Marrow Transplant; 2019 Apr; 25(4):800-809. PubMed ID: 30521974
[TBL] [Abstract][Full Text] [Related]
25. Ex vivo T-cell-depleted allogeneic stem cell transplantation for hematologic malignancies: The search for an optimum transplant T-cell dose and T-cell add-back strategy.
Anandi P; Tian X; Ito S; Muranski P; Chokshi PD; Watters N; Chawla U; Hensel N; Stroncek DF; Battiwalla M; Barrett AJ
Cytotherapy; 2017 Jun; 19(6):735-743. PubMed ID: 28395942
[TBL] [Abstract][Full Text] [Related]
26. Haploidentical Hematopoietic Cell Transplant with Post-Transplant Cyclophosphamide and Peripheral Blood Stem Cell Grafts in Older Adults with Acute Myeloid Leukemia or Myelodysplastic Syndrome.
Slade M; DiPersio JF; Westervelt P; Vij R; Schroeder MA; Romee R
Biol Blood Marrow Transplant; 2017 Oct; 23(10):1736-1743. PubMed ID: 28688919
[TBL] [Abstract][Full Text] [Related]
27. Allogeneic Hematopoietic Cell Transplantation in Multiple Myeloma: Impact of Disease Risk and Post Allograft Minimal Residual Disease on Survival.
Dhakal B; D'Souza A; Martens M; Kapke J; Harrington AM; Pasquini M; Saber W; Drobyski WR; Zhang MJ; Hamadani M; Hari PN
Clin Lymphoma Myeloma Leuk; 2016 Jul; 16(7):379-86. PubMed ID: 27160644
[TBL] [Abstract][Full Text] [Related]
28. Validation of a Hematopoietic Cell Transplant-Composite Risk (HCT-CR) Model for Post-Transplant Survival Prediction in Patients with Hematologic Malignancies.
Ciurea SO; Kongtim P; Hasan O; Ramos Perez JM; Torres J; Rondon G; Champlin RE
Clin Cancer Res; 2020 May; 26(10):2404-2410. PubMed ID: 32019857
[TBL] [Abstract][Full Text] [Related]
29. Outcomes after Second Hematopoietic Stem Cell Transplantations in Pediatric Patients with Relapsed Hematological Malignancies.
Naik S; Martinez C; Leung K; Sasa G; Nguyen NY; Wu MF; Gottschalk S; Brenner M; Heslop H; Krance R
Biol Blood Marrow Transplant; 2015 Jul; 21(7):1266-72. PubMed ID: 25765555
[TBL] [Abstract][Full Text] [Related]
30. Pre-transplant short telomeres are associated with high mortality risk after unrelated donor haematopoietic cell transplant for severe aplastic anaemia.
Wang Y; McReynolds LJ; Dagnall C; Katki HA; Spellman SR; Wang T; Hicks B; Freedman ND; Jones K; Lee SJ; Savage SA; Gadalla SM
Br J Haematol; 2020 Jan; 188(2):309-316. PubMed ID: 31426123
[TBL] [Abstract][Full Text] [Related]
31. Survival of Lymphoma Patients Experiencing Relapse or Progression after an Allogeneic Hematopoietic Cell Transplantation.
Epperla N; Hamadani M; Ahn KW; He F; Kodali D; Kleman A; Hari PN; Pasquini M; Fenske TS; Craig MD; Kanate AS; Bachanova V
Biol Blood Marrow Transplant; 2018 May; 24(5):983-988. PubMed ID: 29410340
[TBL] [Abstract][Full Text] [Related]
32. Changes of telomere length in children after hematopoietic stem cell transplantation.
Akiyama M; Hoshi Y; Sakurai S; Yamada H; Yamada O; Mizoguchi H
Bone Marrow Transplant; 1998 Jan; 21(2):167-71. PubMed ID: 9489634
[TBL] [Abstract][Full Text] [Related]
33. Nonmyeloablative allogeneic hematopoietic stem cell transplant for the treatment of patients with hematologic malignancies using busulfan, fludarabine, and total body irradiation conditioning is effective in an elderly and infirm population.
Brammer JE; Stentz A; Gajewski J; Curtin P; Hayes-Lattin B; Kovacsovics T; Leis JF; Meyers G; Nemecek E; Subbiah N; Frires R; Palmbach G; Avraham GP; Slater S; Maziarz RT
Biol Blood Marrow Transplant; 2015 Jan; 21(1):89-96. PubMed ID: 25445641
[TBL] [Abstract][Full Text] [Related]
34. Whole-Body Lung Function Test-Derived Outcome Predictors in Allogenic Stem Cell Transplantation.
Scheidl S; Zinke-Cerwenka W; Flick H; Gaal S; Avian A; Greinix H; Olschewski H
Biol Blood Marrow Transplant; 2019 Jan; 25(1):129-136. PubMed ID: 30064013
[TBL] [Abstract][Full Text] [Related]
35. Telomere length changes in patients undergoing hematopoietic stem cell transplantation.
Lee J; Kook H; Chung I; Kim H; Park M; Kim C; Nah J; Hwang T
Bone Marrow Transplant; 1999 Aug; 24(4):411-5. PubMed ID: 10467331
[TBL] [Abstract][Full Text] [Related]
36. Clonal hematopoiesis in donors and long-term survivors of related allogeneic hematopoietic stem cell transplantation.
Boettcher S; Wilk CM; Singer J; Beier F; Burcklen E; Beisel C; Ventura Ferreira MS; Gourri E; Gassner C; Frey BM; Schanz U; Skoda RC; Ebert BL; Brummendorf TH; Beerenwinkel N; Manz MG
Blood; 2020 Apr; 135(18):1548-1559. PubMed ID: 32181816
[TBL] [Abstract][Full Text] [Related]
37. P2X7 receptor polymorphism and clinical outcomes in HLA-matched sibling allogeneic hematopoietic stem cell transplantation.
Lee KH; Park SS; Kim I; Kim JH; Ra EK; Yoon SS; Hong YC; Park S; Kim BK
Haematologica; 2007 May; 92(5):651-7. PubMed ID: 17488689
[TBL] [Abstract][Full Text] [Related]
38. What the internist should know about stem cell transplant in the elderly patient.
Medinger M; Passweg J
Eur J Intern Med; 2018 Dec; 58():43-47. PubMed ID: 29960832
[TBL] [Abstract][Full Text] [Related]
39. Melphalan-Based Reduced-Intensity Conditioning is Associated with Favorable Disease Control and Acceptable Toxicities in Patients Older Than 70 with Hematologic Malignancies Undergoing Allogeneic Hematopoietic Stem Cell Transplantation.
Al Malki MM; Nathwani N; Yang D; Armenian S; Dadwal S; Salman J; Mokhtari S; Cao T; Sandhu K; Rouse M; Mei M; Ali H; Parker P; Alvarnas J; Smith E; Donnell MO; Marcucci G; Snyder D; Nademanee A; Forman SJ; Stein A; Nakamura R
Biol Blood Marrow Transplant; 2018 Sep; 24(9):1828-1835. PubMed ID: 29753158
[TBL] [Abstract][Full Text] [Related]
40. Partially matched, nonmyeloablative allogeneic transplantation: clinical outcomes and immune reconstitution.
Rizzieri DA; Koh LP; Long GD; Gasparetto C; Sullivan KM; Horwitz M; Chute J; Smith C; Gong JZ; Lagoo A; Niedzwiecki D; Dowell JM; Waters-Pick B; Liu C; Marshall D; Vredenburgh JJ; Gockerman J; Decastro C; Moore J; Chao NJ
J Clin Oncol; 2007 Feb; 25(6):690-7. PubMed ID: 17228020
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
